Front Row Advisors LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 14,392 shares of the company’s stock, valued at approximately $1,086,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Chip Partners Inc. grew its holdings in Colgate-Palmolive by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after purchasing an additional 8 shares during the period. AlphaMark Advisors LLC grew its holdings in Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. Weatherstone Capital Management grew its holdings in Colgate-Palmolive by 0.7% in the second quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock valued at $302,000 after purchasing an additional 28 shares during the period. Dorsey & Whitney Trust CO LLC grew its holdings in Colgate-Palmolive by 0.6% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock valued at $419,000 after purchasing an additional 34 shares during the period. Finally, Jackson Grant Investment Advisers Inc. grew its holdings in Colgate-Palmolive by 0.5% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock valued at $521,000 after purchasing an additional 35 shares during the period. Institutional investors and hedge funds own 73.10% of the company’s stock.

In other news, VP Henning I. Jakobsen sold 36,215 shares of the business’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the transaction, the vice president now directly owns 70,783 shares of the company’s stock, valued at $5,041,165.26. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 327,451 shares of company stock worth $23,534,707. 1.02% of the stock is currently owned by corporate insiders.

Colgate-Palmolive (CL) opened at $68.95 on Friday. The firm has a market cap of $61,616.64, a P/E ratio of 30.24, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. Colgate-Palmolive has a 12-month low of $66.26 and a 12-month high of $77.91.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.75. The firm had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. Colgate-Palmolive’s revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.75 earnings per share. equities research analysts predict that Colgate-Palmolive will post 3.18 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.32%. Colgate-Palmolive’s dividend payout ratio (DPR) is 70.18%.

A number of equities research analysts recently issued reports on the stock. Jefferies Group restated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Friday, January 26th. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Citigroup lowered their target price on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Finally, Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $77.71.

WARNING: “Front Row Advisors LLC Invests $1.09 Million in Colgate-Palmolive (CL)” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2018/02/09/front-row-advisors-llc-invests-1-09-million-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.